121 related articles for article (PubMed ID: 34244538)
21. A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolism.
Håglin L; Bäckman L; Törnkvist B
Cardiovasc Diabetol; 2011 Dec; 10():116. PubMed ID: 22192330
[TBL] [Abstract][Full Text] [Related]
22. Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC Study.
Bebu I; Braffett BH; de Boer IH; Aiello LP; Bantle JP; Lorenzi GM; Herman WH; Gubitosi-Klug RA; Perkins BA; Lachin JM; Molitch ME
Diabetes Care; 2023 Feb; 46(2):361-368. PubMed ID: 36520643
[TBL] [Abstract][Full Text] [Related]
23. Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes.
Habes M; Jacobson AM; Braffett BH; Rashid T; Ryan CM; Shou H; Cui Y; Davatzikos C; Luchsinger JA; Biessels GJ; Bebu I; Gubitosi-Klug RA; Bryan RN; Nasrallah IM;
JAMA Netw Open; 2023 Jun; 6(6):e2316182. PubMed ID: 37261829
[TBL] [Abstract][Full Text] [Related]
24. Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications).
Pop-Busui R; Cleary PA; Braffett BH; Martin CL; Herman WH; Low PA; Lima JAC; Bluemke DA;
J Am Coll Cardiol; 2013 Jan; 61(4):447-454. PubMed ID: 23265339
[TBL] [Abstract][Full Text] [Related]
25. Testosterone Concentrations and Cardiovascular Autonomic Neuropathy in Men with Type 1 Diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC).
Kim C; Pop-Busui R; Braffett B; Cleary PA; Bebu I; Wessells H; Orchard T; Sarma AV;
J Sex Med; 2015 Nov; 12(11):2153-9. PubMed ID: 26559501
[TBL] [Abstract][Full Text] [Related]
26. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
Braffett BH; Dagogo-Jack S; Bebu I; Sivitz WI; Larkin M; Kolterman O; Lachin JM;
Diabetes Care; 2019 Apr; 42(4):657-664. PubMed ID: 30728218
[TBL] [Abstract][Full Text] [Related]
27. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
; Orchard TJ; Nathan DM; Zinman B; Cleary P; Brillon D; Backlund JY; Lachin JM
JAMA; 2015 Jan; 313(1):45-53. PubMed ID: 25562265
[TBL] [Abstract][Full Text] [Related]
28. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D.
Basu A; Bebu I; Jenkins AJ; Stoner JA; Zhang Y; Klein RL; Lopes-Virella MF; Garvey WT; Budoff MJ; Alaupovic P; Lyons TJ;
J Lipid Res; 2019 Aug; 60(8):1432-1439. PubMed ID: 31203233
[TBL] [Abstract][Full Text] [Related]
29. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Monnier VM; Sun W; Gao X; Sell DR; Cleary PA; Lachin JM; Genuth S;
Cardiovasc Diabetol; 2015 Sep; 14():118. PubMed ID: 26341632
[TBL] [Abstract][Full Text] [Related]
30. Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
Soliman EZ; Backlund JC; Bebu I; Orchard TJ; Zinman B; Lachin JM;
Diabetes Care; 2017 Jun; 40(6):793-799. PubMed ID: 28302651
[TBL] [Abstract][Full Text] [Related]
31. The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study.
Tian Y; Chen K; Xie Z; Fang Y; Wang H; Nie Y; Hu D; Mu Y
BMC Cardiovasc Disord; 2015 Jul; 15():66. PubMed ID: 26160354
[TBL] [Abstract][Full Text] [Related]
32. Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
Writing Group for the DCCT/EDIC Research Group
Diabetes Care; 2016 Sep; 39(9):1621-30. PubMed ID: 27436274
[TBL] [Abstract][Full Text] [Related]
33. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
[TBL] [Abstract][Full Text] [Related]
34. Uric acid and the development of metabolic syndrome in women and men.
Sui X; Church TS; Meriwether RA; Lobelo F; Blair SN
Metabolism; 2008 Jun; 57(6):845-52. PubMed ID: 18502269
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine.
Tecce N; Masulli M; Lupoli R; Della Pepa G; Bozzetto L; Palmisano L; Rivellese AA; Riccardi G; Capaldo B
Cardiovasc Diabetol; 2020 Oct; 19(1):166. PubMed ID: 33010807
[TBL] [Abstract][Full Text] [Related]
36. Is serum urate causally associated with incident cardiovascular disease?
Thornley S; Marshall RJ; Jackson R; Gentles D; Dalbeth N; Crengle S; Kerr A; Wells S
Rheumatology (Oxford); 2013 Jan; 52(1):135-42. PubMed ID: 23065317
[TBL] [Abstract][Full Text] [Related]
37. Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
Bebu I; Braffett BH; Orchard TJ; Lorenzi GM; Lachin JM;
Diabetes Care; 2019 Jul; 42(7):1284-1289. PubMed ID: 30894365
[TBL] [Abstract][Full Text] [Related]
38. Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study.
Ong G; Davis WA; Davis TM
Diabetologia; 2010 Jul; 53(7):1288-94. PubMed ID: 20349345
[TBL] [Abstract][Full Text] [Related]
39. Variability in benefit from intensive insulin therapy on cardiovascular events in individuals with type 1 diabetes: A post hoc analysis of the DCCT/EDIC study.
Helmink MAG; Hageman SHJ; Visseren FLJ; de Ranitz-Greven WL; de Valk HW; van Sloten TT; Westerink J
Diabet Med; 2023 Nov; 40(11):e15183. PubMed ID: 37470718
[TBL] [Abstract][Full Text] [Related]
40. The dose-response effects of uric acid on the prevalence of metabolic syndrome and electrocardiographic left ventricular hypertrophy in healthy individuals.
Liu CW; Chen KH; Tseng CK; Chang WC; Wu YW; Hwang JJ
Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):30-38. PubMed ID: 30545672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
